Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab

Por: Ars Technica Science October 12, 2022

thumbnail

Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake Worth, Florida. Share this story The nasal version of the Oxford/AstraZeneca COVID-19 vaccine failed an early-stage clinical trial, dashing hopes for better infection... + full article



Similar News

Nasal COVID vaccine fails to offer desired protection in testing

The Hill USA Health October 12, 2022

thumbnailA recent clinical trial has found less-than-promising results for a nasally administered version of AstraZeneca’s COVID-19 vaccine, with immune responses observed in only “a minority of participants.” University of Oxford researchers that not only were antibody responses... + más

Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica


After Giving Up on Cancer Vaccines, Doctors Start to Find Hope

The New York Times USA Health October 10, 2022

thumbnailIt seems like an almost impossible dream — a cancer vaccine that would protect healthy people at high risk of cancer. Any incipient malignant cells would be obliterated by the immune system. It would be no different from the way vaccines protect against infectious... + más

The Race to Make a Vaccine for Breast Cancer | Time

Mammograms: 3 key questions women should ask before cancer scans | New York Post


Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities

Forbes USA Business October 03, 2022

thumbnailGreenphire is working to make clinical trials more equitable and accessible to everyone. Google Images Clinical trial company Greenphire as “the leading provider of global financial lifecycle management solutions for clinical trials, delivering the most complete data and... + más

Market turbulence, inflation, geopolitical uncertainty prompt dip in fintech investment: KPMG | Fox Business

Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A | The Advocate


For intranasal vaccines, big talk comes cheap, but the money is still missing

The Boston Globe USA Business September 30, 2022

thumbnailThe vision is enticing: replacing the pain of a vaccine shot with a nasal spray that is powerful enough to prevent even mild infections and short-circuit the global spread of COVID-19.Even as Americans roll up their sleeves for updated fall boosters, with the potential to evade... + más

The best budget laptop of 2022 | The Verge

Study looks into potential link between child vaccines and asthma | The Boston Globe


A single dose of monkeypox vaccine provides some protection against infection, CDC says

CNBC USA Health September 28, 2022

thumbnailLos Angeles, CA - August 10: Luis Garcia, a registered nurse, prepares Monkeypox virus vaccine at St.John's Well Child & Family Center on Wednesday, Aug. 10, 2022 in Los Angeles, CA.Irfan Khan Los Angeles Times Getty ImagesPeople at risk for monkeypox who have not received... + más

The First U.S. Data Show the Monkeypox Vaccine Is Effective | Time

HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC


CDC Has ‘Cautious Optimism’ Monkeypox Vax Is Slowing Spread

The Daily Beast USA Politics September 28, 2022

thumbnailPatients who have been vaccinated against the monkeypox virus were 14 times less likely to become infected than those who had not been vaccinated, according to initial data released by the Centers for Disease Control and Prevention on Wednesday, which public health officials say... + más

HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC

Los Angeles health officials are investigating the death of a person who had monkeypox | CNBC


'Updated Covid Vaccine Will Help Restore Protection Waned Since Previous Vaccination'

RTTNews USA Health September 24, 2022

thumbnailGetting an updated Covid vaccine this fall will help restore protection that has waned since previous vaccination, according to the White House Covid-19 Response Team.Laboratory data suggests that the addition of the Omicron BA.4 and BA.5 spike protein components may help... + más

Pfizer, BioNTech ask FDA to approve updated COVID booster for ages 5-11 | WPTV

US officially added to WHO’s list of poliovirus outbreak countries | Ars Technica



About iurex | Privacy Policy | Disclaimer |